Search
Please see below for a list of search results.
The Authority – the HTA’s non-executive board – is made-up of a Chair and eleven Members:
Deployment underpins both our Delivery and Development activity; it is the choices we make about how we best manage our people and resources.
To ensure that the HTA’s regulatory approach remains relevant, we actively prepare for the future. We do this through our development activities, which seek to ensure public confidence will be maintained as new and innovative uses of...
This is the second year of our current three-year Strategy, where against a backdrop of scientific, economic and political change, our core purpose remains undiminished - to ensure that human tissue and organs
Protecting public and professional confidence requires us to protect the foundations on which confidence is built. We believe that confidence is maintained if the core principles contained within the HT Act are adhered to. These principles are:
The HTA is an Executive Non-Departmental Public Body sponsored by the Department of Health. We were established under the Human Tissue Act 2004 (HT Act) – which covers England, Wales and Northern Ireland – to regulate activities relating to the removal, storage, use and disposal of human tissue...
The HTA recognises that many of our stakeholders work at the cutting edge of science and medicine, often pushing the boundaries of conventional regulation. We will continue to work closely with other regulators in the field (MHRA, HRA and HFEA) to clarify regulatory pathways, and remain...
Last year, we reviewed our joint working protocols and memoranda of understanding with a number of our stakeholders, including the MHRA, HRA and the National Research Ethics Service (NRES). These understandings set out how we share information, should concerns arise about establishments that are...